Last news
The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults

The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults

Notified -...

Breaking the speed limit: Wood Mackenzie warns AI data centre power race threatens projects and consumers

Breaking the speed limit: Wood Mackenzie warns AI data centre power race threatens projects and consumers

Notified -...

Kooth Digital Health Names Fred Bendaña Chief Commercial Officer

Kooth Digital Health Names Fred Bendaña Chief Commercial Officer

Notified -...

Surge in EHS+ Platform Adoption Among Companies with Leaner Operations Signals Broader Market Shift, Cority Reports

Surge in EHS+ Platform Adoption Among Companies with Leaner Operations Signals Broader Market Shift, Cority Reports

Notified -...

General Fusion Appoints Thomas Boehlert to its Board of Directors

General Fusion Appoints Thomas Boehlert to its Board of Directors

Notified -...

Constellation Brands Announces Election of Morgan Flatley as New Independent Board Director

Constellation Brands Announces Election of Morgan Flatley as New Independent Board Director

Notified -...

EIF commits EUR 200 million to Copenhagen Infrastructure Partners to scale European biogas production

EIF commits EUR 200 million to Copenhagen Infrastructure Partners to scale European biogas production

Notified -...

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

Notified -...

1 ... 28 29 30 31 32 33 34 35 36 ... 1127
menu
menu